Clinical Trials
13 trialsNCT05990634 2023-08-14
LifeChamps Feasibility Study
Region Stockholm
Phase NA Unknown
NCT05928962 2023-07-10
An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas
Fujian Cancer Hospital
Phase 1 Unknown
NCT05664139 2023-02-08
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT05313711 2022-04-06
Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers
NHS Grampian
Unknown
NCT04142931 2021-03-24
Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors
Sheba Medical Center
Phase 1 Unknown
NCT02533700 2020-03-10
CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
Shandong Provincial Hospital
Phase 2 Unknown
NCT03643289 2020-02-27
PRIMM
East and North Hertfordshire NHS Trust
Unknown
NCT03986515 2019-06-14
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03353402 2019-04-03
Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy
Sheba Medical Center
Phase 1 Unknown
NCT03383237 2017-12-27
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03285230 2017-09-19
E3N
Institut National de la Santé Et de la Recherche Médicale, France
Unknown
NCT00287131 2012-03-29
Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
Sheba Medical Center
Phase 2 Unknown
NCT00111046 2005-11-10
Pain Relief - Tramadol Versus Ibuprofen
Royal Liverpool University Hospital
Phase 1/2 Unknown